Hand Function after Distal Radial Access: Is it Safe?

The benefit of the transradial approach in percutaneous interventions is well known. Its main limitation is radial artery occlusion (RAO) which would compromise the artery for future use in percutaneous procedures. Even though it is clinically silent, reported cases might reach 33%. 

Función de la mano luego del acceso radial distal, ¿es seguro?

More recently, the distal radial access (DRA) has surged as an alternative to reduce RAO. However, its safety and potential to produce negative effects in hand function have not been studied yet. 

The aim of this prospective, multicenter, cohort study was to assess hand function at long term in patients treated with DRA for coronary procedures. 

Multiple outcomes were presented to assess hand dysfunction, including coordination questionnaires, dexterity, strength, and sensation tests up to 12-month followup. 

The study looked at 313 patients. Mean age was 66 and they were mostly men. 22% presented prior radial access. As regards procedure characteristics, 54% of DRA was left, ultrasound was used to guide puncture in 85 % of cases, and they were mostly diagnostic procedures. DRA failed in 2.9% of cases. 

Read also: FFR and IFR: Are We Talking About the Same Thing?

DRA showed no hand function deterioration according to the questionnaires for subjective and objective assessment and was even associated to less pain and <1% RAO rate.  

Conclusion 

The distal radial access was not associated with worse hand function. On the contrary, it was associated to lower complications rate with good tolerance to the procedure. 

Dr. Andrés Rodríguez
Member of the editorial board of SOLACI.org.

Original Title: International Hand Function Study Following Distal Radial Access The RATATOUILLE Study.

Reference: Gregory A. Sgueglia, MD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...